collection
https://read.qxmd.com/read/37088277/chatgpt-outscored-human-candidates-in-a-virtual-objective-structured-clinical-examination-in-obstetrics-and-gynecology
#1
JOURNAL ARTICLE
Sarah W Li, Matthew W Kemp, Susan J S Logan, Pooja Sharma Dimri, Navkaran Singh, Citra N Z Mattar, Pradip Dashraath, Harshaana Ramlal, Aniza P Mahyuddin, Suren Kanayan, Sean W D Carter, Serene P T Thain, Erin L Fee, Sebastian E Illanes, Mahesh A Choolani
BACKGROUND: Natural language processing is a form of artificial intelligence that allows human users to interface with a machine without using complex codes. The ability of natural language processing systems, such as ChatGPT, to successfully engage with healthcare systems requiring fluid reasoning, specialist data interpretation, and empathetic communication in an unfamiliar and evolving environment is poorly studied. This study investigated whether the ChatGPT interface could engage with and complete a mock objective structured clinical examination simulating assessment for membership of the Royal College of Obstetricians and Gynaecologists...
August 2023: American Journal of Obstetrics and Gynecology
https://read.qxmd.com/read/37043625/monitoring-fast-synaptic-transmission-of-neuromodulatory-transmitters-to-define-drug-effects-in-the-brain
#2
JOURNAL ARTICLE
Brooke A Christensen, Erin S Calipari
Catecholaminergic systems are involved in a range of psychiatric disorders and are central mediators of the effects of stimulants on the brain and behavior. Advances in analytical detection methods paired with creative application of these approaches allow for recording noradrenergic and dopaminergic systems in the brain in isolation with subsecond resolution. Pauly et al. ( ACS Chem. Neurosci. 2023, 10.1021/acschemneuro.2c00689) define the distinct and differential mechanisms of methamphetamine enantiomers on dopamine and norepinephrine release, giving critical insights into the pharmacodynamic properties of a stimulant that is both abused and used clinically...
May 3, 2023: ACS Chemical Neuroscience
https://read.qxmd.com/read/36942075/donepezil-beyond-alzheimer-s-disease-a-narrative-review-of-therapeutic-potentials-of-donepezil-in-different-diseases
#3
REVIEW
Parham Pooladgar, Mehdi Sakhabakhsh, Arsia Taghva, Saeed Soleiman-Meigooni
Donepezil hydrochloride is an acetylcholine esterase inhibitor studied and approved to treat Alzheimer's disease (AD). However, this drug can have positive therapeutic potential in treating different conditions, including various neurodegenerative disorders such as other types of dementia, multiple sclerosis, Parkinson's disease, psychiatric and mood disorders, and even infectious diseases. Hence, this study reviewed the therapeutic potential of this drug in treating Alzheimer's and other diseases by reviewing the articles from databases including Web of Science, Scopus, PubMed, Cochrane, and Science Direct...
December 2022: Iranian Journal of Pharmaceutical Research: IJPR
https://read.qxmd.com/read/36171828/psychedelics-their-limited-understanding-and-future-in-the-treatment-of-chronic-pain
#4
REVIEW
Vedant N Hedau, Ashish P Anjankar
Psychedelics are hallucinogenic drugs that alter the state of consciousness substantially. They bring about psychological, auditory, and visual changes. The psychedelics act on the brain, implying that they have a powerful psychological impact. One of the main factors contributing to disability worldwide is pain. The majority of people deal with pain on a daily basis. Living with chronic pain affects daily life and has social implications. Chronic pain can be associated with any disease that may be genetic, idiopathic, or traumatic...
August 2022: Curēus
https://read.qxmd.com/read/36142247/targeting-nmda-receptors-at-the-neurovascular-unit-past-and-future-treatments-for-central-nervous-system-diseases
#5
REVIEW
Célia Seillier, Flavie Lesept, Olivier Toutirais, Fanny Potzeha, Manuel Blanc, Denis Vivien
The excitatory neurotransmission of the central nervous system (CNS) mainly involves glutamate and its receptors, especially N-methyl-D-Aspartate receptors (NMDARs). These receptors have been extensively described on neurons and, more recently, also on other cell types. Nowadays, the study of their differential expression and function is taking a growing place in preclinical and clinical research. The diversity of NMDAR subtypes and their signaling pathways give rise to pleiotropic functions such as brain development, neuronal plasticity, maturation along with excitotoxicity, blood-brain barrier integrity, and inflammation...
September 7, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/36133805/regulatory-mechanisms-of-tetramethylpyrazine-on-central-nervous-system-diseases-a-review
#6
REVIEW
Yue Liu, Guang Yang, Wenqiang Cui, Yunling Zhang, Xiao Liang
Central nervous system (CNS) diseases can lead to motor, sensory, speech, cognitive dysfunction, and sometimes even death. These diseases are recognized to cause a substantial socio-economic impact on a global scale. Tetramethylpyrazine (TMP) is one of the main active ingredients extracted from the Chinese herbal medicine Ligusticum striatum DC . (Chuan Xiong). Many in vivo and in vitro studies have demonstrated that TMP has a certain role in the treatment of CNS diseases through inhibiting calcium ion overload and glutamate excitotoxicity, anti-oxidative/nitrification stress, mitigating inflammatory response, anti-apoptosis, protecting the integrity of the blood-brain barrier (BBB) and facilitating synaptic plasticity...
2022: Frontiers in Pharmacology
https://read.qxmd.com/read/35965783/glucagon-like-peptide-1-and-glucose-dependent-insulinotropic-peptide-hormones-and-novel-receptor-agonists-protect-synapses-in-alzheimer-s-and-parkinson-s-diseases
#7
REVIEW
Christian Hölscher
Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) are peptide hormones and growth factors. A major pathological feature of both Alzheimer's dis-ease (AD) and Parkinson's disease (PD) is the loss of synaptic transmission in the cortex in AD and the loss of dopaminergic synapses in the nigra-striatal dopaminergic projection. Several studies demonstrate that GLP-1 and GIP receptor agonists protect synapses and synaptic transmission from the toxic events that underlie AD and PD...
2022: Frontiers in Synaptic Neuroscience
https://read.qxmd.com/read/35745861/antioxidative-nac-loaded-silk-nanoparticles-with-opening-mucosal-tight-junctions-for-nasal-drug-delivery-an-in-vitro-and-in-vivo-study
#8
JOURNAL ARTICLE
Tze-Wen Chung, Ting-Ya Wu, Zheng-Yu Siah, Der-Zen Liu
Using nasal routes to deliver drugs to the brain using multifunctional nanoparticles (NPs) to bypass the blood-brain barrier (BBB) might enhance the delivery efficacy. Anti-oxidative N-Acetyl-L-cysteine (NAC)-loaded silk fibroin (SF/NAC) NPs are produced, characterized and studied as a potential delivery vehicle for NAC delivered to the brain via nasal for both in vitro and in vivo studies. The NPs are not cytotoxic to RPMI 2650 cells, mucosal model cells, at a concentration of 6000 μg/mL. The anti-oxidative activities of SF/NAC NPs are demonstrated by high H2 O2 scavenge capacities of the NPs and shown by mitochondrial superoxide (MitoSOX) immunostaining of human mesenchymal stem cells...
June 17, 2022: Pharmaceutics
https://read.qxmd.com/read/35903343/the-antioxidant-n-acetyl-l-cysteine-restores-the-behavioral-deficits-in-a-neurodevelopmental-model-of-schizophrenia-through-a-mechanism-that-involves-nitric-oxide
#9
JOURNAL ARTICLE
Ana Lopes-Rocha, Thiago Ohno Bezerra, Roberta Zanotto, Inda Lages Nascimento, Angela Rodrigues, Cristiane Salum
The disruption of neurodevelopment is a hypothesis for the emergence of schizophrenia. Some evidence supports the hypothesis that a redox imbalance could account for the developmental impairments associated with schizophrenia. Additionally, there is a deficit in glutathione (GSH), a main antioxidant, in this disorder. The injection of metilazoximetanol acetate (MAM) on the 17th day of gestation in Wistar rats recapitulates the neurodevelopmental and oxidative stress hypothesis of schizophrenia. The offspring of rats exposed to MAM treatment present in early adulthood behavioral and neurochemical deficits consistent with those seen in schizophrenia...
2022: Frontiers in Pharmacology
https://read.qxmd.com/read/35910331/acidic-cannabinoids-suppress-proinflammatory-cytokine-release-by-blocking-store-operated-calcium-entry
#10
REVIEW
Malika Faouzi, Clay Wakano, Mahealani K Monteilh-Zoller, Ram P Neupane, John G Starkus, Jayanti Bhandari Neupane, Aaron J Cullen, Brandon E Johnson, Andrea Fleig, Reinhold Penner
Cannabis sativa has long been known to affect numerous biological activities. Although plant extracts, purified cannabinoids, or synthetic cannabinoid analogs have shown therapeutic potential in pain, inflammation, seizure disorders, appetite stimulation, muscle spasticity, and treatment of nausea/vomiting, the underlying mechanisms of action remain ill-defined. In this study we provide the first comprehensive overview of the effects of whole-plant Cannabis extracts and various pure cannabinoids on store-operated calcium (Ca2+ ) entry (SOCE) in several different immune cell lines...
2022: Function
https://read.qxmd.com/read/35916437/6-monoacetylmorphine-antibody-distribution-in-tissues-from-heroin-related-death-cases-an-experimental-study-to-investigate-the-distributive-response
#11
JOURNAL ARTICLE
Aniello Maiese, Raffaele La Russa, Maria Chiara David, Santina Cantatore, Alice Chiara Manetti, Alessandra De Matteis, Costantino Ciallella, Paola Frati, Vittorio Fineschi
Heroin, a semisynthetic opioid drug synthesized from morphine, is the 3,6-diacetyl ester of morphine (diacetylmorphine). The post-mortem diagnosis of heroin-related death could be an issue and usually rely on a combination of investigations, including the autopsy, histological and toxicological analysis. We conducted the present study to evaluate the correlation between the heroin concentration in biological fluids (peripheral blood, bile and urine) and the post-mortem anti-6-MAM antibody expression in various tissues (brain, heart, lung, liver and kidney) using immunohistochemical staining...
August 2, 2022: Journal of Cellular and Molecular Medicine
https://read.qxmd.com/read/35917043/repetitive-transcranial-magnetic-stimulation-of-the-brain-after-ischemic-stroke-mechanisms-from-animal-models
#12
REVIEW
Ying Xing, Yuqian Zhang, Congqin Li, Lu Luo, Yan Hua, Jian Hu, Yulong Bai
Stroke is a common cerebrovascular disease with high morbidity, mortality, and disability worldwide. Post-stroke dysfunction is related to the death of neurons and impairment of synaptic structure, which results from cerebral ischemic damage. Currently, transcranial magnetic stimulation (TMS) techniques are available to provide clinically effective interventions and quantitative diagnostic and prognostic biomarkers. The development of TMS has been 40 years and a range of repetitive TMS (rTMS) protocols are now available to regulate neuronal plasticity in many neurological disorders, such as stroke, Parkinson disease, psychiatric disorders, Alzheimer disease, and so on...
May 2023: Cellular and Molecular Neurobiology
https://read.qxmd.com/read/35854107/the-serotonin-theory-of-depression-a-systematic-umbrella-review-of-the-evidence
#13
Joanna Moncrieff, Ruth E Cooper, Tom Stockmann, Simone Amendola, Michael P Hengartner, Mark A Horowitz
The serotonin hypothesis of depression is still influential. We aimed to synthesise and evaluate evidence on whether depression is associated with lowered serotonin concentration or activity in a systematic umbrella review of the principal relevant areas of research. PubMed, EMBASE and PsycINFO were searched using terms appropriate to each area of research, from their inception until December 2020. Systematic reviews, meta-analyses and large data-set analyses in the following areas were identified: serotonin and serotonin metabolite, 5-HIAA, concentrations in body fluids; serotonin 5-HT1A receptor binding; serotonin transporter (SERT) levels measured by imaging or at post-mortem; tryptophan depletion studies; SERT gene associations and SERT gene-environment interactions...
August 2023: Molecular Psychiatry
https://read.qxmd.com/read/35871344/long-term-depression-inducing-low-frequency-stimulation-enhances-p-tau181-and-p-tau217-in-an-age-dependent-manner-in-live-rats
#14
JOURNAL ARTICLE
Yangyang Zhang, Yin Yang, Zhengtao Hu, Manyi Zhu, Shuangying Qin, Pengpeng Yu, Bo Li, Jitian Xu, Tomas Ondrejcak, Igor Klyubin, Michael J Rowan, Neng-Wei Hu
BACKGROUND: Cognitive decline in Alzheimer's disease (AD) correlates with the extent of tau pathology, in particular tau hyperphosphorylation, which is strongly age-associated. Although elevation of cerebrospinal fluid or blood levels of phosphorylated tau (p-Tau) at residues Thr181 (p-Tau181), Thr217 (p-Tau217), and Thr231 (p-Tau231) are proposed to be particularly sensitive markers of preclinical AD, the generation of p-Tau during brain activity is poorly understood. OBJECTIVE: To study whether the expression levels of p-Tau181, p-Tau217, and p-Tau231 can be enhanced by physiological synaptic long-term depression (LTD) which has been linked to the enhancement of p-Tau in hippocampus...
July 18, 2022: Journal of Alzheimer's Disease: JAD
https://read.qxmd.com/read/35843407/humanin-derivative-hng-enhances-neurotransmitter-release
#15
JOURNAL ARTICLE
Natsumi Ikegawa, Ayari Kozuka, Nozomi Morita, Minetaka Murakami, Nobuyuki Sasakawa, Takako Niikura
BACKGROUND: Humanin (HN) is an endogenous 24-residue peptide that was first identified as a protective factor against neuronal death in Alzheimer's disease (AD). We previously demonstrated that the highly potent HN derivative HNG (HN with substitution of Gly for Ser14) ameliorated cognitive impairment in AD mouse models. Despite the accumulating evidence on the antagonizing effects of HN against cognitive deficits, the mechanisms behind these effects remain to be elucidated. METHODS: The extracellular fluid in the hippocampus of wild-type young mice was collected by microdialysis and the amounts of neurotransmitters were measured...
July 14, 2022: Biochimica et Biophysica Acta. General Subjects
https://read.qxmd.com/read/2859077/amphetamine-mazindol-and-fencamfamin-in-narcolepsy
#16
RANDOMIZED CONTROLLED TRIAL
J Shindler, M Schachter, S Brincat, J D Parkes
Twenty patients with the narcoleptic syndrome were treated separately with dexamphetamine sulphate tablets 10 and 30 mg, Dexedrine Spansules 10 mg, mazindol 4 mg, and fencamfamin hydrochloride 60 mg daily. Each drug was given for four weeks and the effects compared. In these dosages the reported frequency of attacks of narcolepsy was roughly halved with each treatment, dexamphetamine 30 mg daily being only slightly more potent than 10 mg. The subjective effects of Dexedrine tablets and Spansules could not be distinguished by most patients...
April 20, 1985: British Medical Journal (1981-1988)
https://read.qxmd.com/read/30127276/the-effect-of-agomelatine-treatment-on-diabetes-induced-cognitive-impairments-in-rats-concomitant-alterations-in-the-hippocampal-neuron-numbers
#17
JOURNAL ARTICLE
Özgür Devrim Can, Umut İrfan Üçel, Ümide Demir Özkay, Emel Ulupınar
Researches that are related to the central nervous system complications of diabetes have indicated higher incidence of cognitive disorders in patients. Since the variety of nootropic drugs used in clinics is limited and none of them consistently improves the outcomes, new and effective drug alternatives are needed for the treatment of diabetes-induced cognitive disorders. Based on the nootropic potential of agomelatine, the promising efficacy of this drug on cognitive impairments of diabetic rats was investigated in the current study...
August 20, 2018: International Journal of Molecular Sciences
https://read.qxmd.com/read/30147009/herbal-and-holistic-solutions-for-neurodegenerative-and-depressive-disorders-leads-from-ayurveda
#18
REVIEW
Rohit Sharma, Atul Kabra, M M Rao, P K Prajapati
Neuropsychiatric and neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, schizophrenia, epilepsy, depression and anxiety pose a sizable global health problem, accompanying substantial burden of disorders, suicides, physical comorbidities, high fiscal expenses, and poor quality of life. There is a recent upsurge in global interest toward the area of traditional therapies and phytomedicines are widely admired by researchers owing to their natural source and fewer side effects. On the contrary, conventional synthetic drugs have been reported with undesirable but inevitable ill effects having poor patient compliance...
2018: Current Pharmaceutical Design
https://read.qxmd.com/read/31023334/ethical-aspects-of-the-abuse-of-pharmaceutical-enhancements-by-healthy-people-in-the-context-of-improving-cognitive-functions
#19
JOURNAL ARTICLE
Tina Tomažič, Anita Kovačič Čelofiga
Better memory, greater motivation and concentration lead to greater productivity, efficiency and performance, all of which are features that are highly valued in a modern society focused on productivity. In the effort for better cognitive abilities, otherwise healthy individuals use cognitive enhancers (also known as nootropics), medicines for the treatment of cognitive deficits of patients with various disorders and health problems, such as Alzheimer's disease, schizophrenia, stroke, Attention Deficit Hyperactivity Disorder or ageing...
April 25, 2019: Philosophy, Ethics, and Humanities in Medicine: PEHM
https://read.qxmd.com/read/31392356/dopaminergic-d1-receptor-signalling-is-necessary-but-not-sufficient-for-cued-fear-memory-destabilisation
#20
JOURNAL ARTICLE
Charlotte R Flavell, Jonathan L C Lee
RATIONALE: Pharmacological targeting of memory reconsolidation is a promising therapeutic strategy for the treatment of fear memory-related disorders. However, the success of reconsolidation-based approaches depends upon the effective destabilisation of the fear memory by memory reactivation. OBJECTIVES: Here, we aimed to determine the functional involvement of dopamine D1 receptors in cued fear memory destabilisation, using systemic drug administration. RESULTS: We observed that direct D1 receptor agonism was not sufficient to stimulate tone fear memory destabilisation to facilitate reconsolidation disruption by the glucocorticoid receptor antagonist mifepristone...
December 2019: Psychopharmacology
label_collection
label_collection
6596
1
2
2022-04-24 03:40:41
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.